ESSA Pharma Inc. (NASDAQ:EPIX) previous close was $32.32 while the outstanding shares total 36.48M. The firm has a beta of 1.63. EPIX’s shares traded higher over the last trading session, gaining 1.18% on 05/27/21. The shares fell to a low of $31.10 before closing at $32.70. Intraday shares traded counted 0.58 million, which was -144.78% lower than its 30-day average trading volume of 237.91K. The stock’s Relative Strength Index (RSI) is 60.35, with weekly volatility at 6.04% and ATR at 2.01. The EPIX stock’s 52-week price range has touched low of $4.36 and a $36.00 high.
Investors have identified the Biotechnology company ESSA Pharma Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $1.32 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
ESSA Pharma Inc. (EPIX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 209.38 million total, with 3.18 million as their total liabilities.
Potential earnings growth for ESSA Pharma Inc. (EPIX)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/17/2021 quarter of the year, ESSA Pharma Inc. recorded a total of 11.88 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 19.47% coming in sequential stages and their sales for the 08/17/2021 quarter increasing by 43.66%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent -11.88 million trying to sell their products during the last quarter, with the result yielding a gross income of -1.08 million. This allows shareholders to hold on to 36.48M with the recently reported earning now reading -0.36 cents per share. This is a figure that compared to analyst’s prediction for their 08/17/2021 (-0.36 cents a share).
Having a look at the company’s valuation, the company is expected to record -1.25 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on EPIX sounds very interesting.
Is the stock of EPIX attractive?
In related news, Director, BERGER FRANKLIN M bought 57,000 shares of the company’s stock in a transaction that recorded on Feb 22. The purchase was performed at an average price of 27.00, for a total value of 1,539,000. In the last 6 months, insiders have changed their ownership in shares of company stock by 2.40%.